The Conversation Has Changed For Stage III Melanoma
Stage III Melanoma—High Risk for Recurrence and (Now) Multiple Options Stage III adjuvant treatment options were for many years limited…
06/11/2019
The Conversation Has Changed For Stage III Melanoma
Stage III Melanoma—High Risk for Recurrence and (Now) Multiple Options Stage III adjuvant treatment options were for many years limited…
|
05/09/2019
What I Want You To Know About Melanoma: Words of Wisdom From a Melanoma Survivor
I was first diagnosed with Stage III melanoma when I was 22 years old. I was a high school and…
|
04/04/2019
AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center
April 5, 2019 (San Rafael, California)… AIM at Melanoma announces the grand opening of the first branch of the International…
|
|
03/20/2019
Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma
AIM at Melanoma will very soon announce the grand opening of the first branch of the International Tissue Bank Consortium…
|
03/19/2019
Melanoma By The State: Arizona
Arizona touts itself as being home to three of the sunniest cities in the United States—Yuma, Phoenix, and Tucson—and for…
|
03/19/2019
Suzanne Lescure: One Woman, One Eye, One Extraordinary Survivor
By Vallerie A. Malkin Suzanne Lescure has always felt lucky. She has a devoted husband. She was able to stay…
|
01/14/2019
Melanoma By The State: Nevada
The seventh largest state in land area in the United States, Nevada boasts a rugged landscape filled with desert valleys…
|
01/14/2019
Tanya Lafontaine, Melanoma Survivor: “I’ve Got This”
by Vallerie A. Malkin Tanya Lafontaine is a 45-year-old mother, fitness professional, and Stage IV melanoma survivor. She is here to…
|
01/10/2019
AIM Launches Peer to Peer Mentoring Program
AIM at Melanoma is pleased to announce Peer Connect, a peer-to-peer mentoring program for anyone touched by melanoma. Here’s how…
11/13/2018
Melanoma International Collaborative Adaptive Trials: Progress Report
The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
|
|
Recent Posts
May. 01, 2024
May is Melanoma Awareneness Month
Apr. 16, 2024
Navigating the Journey Together – Conversations with Melanoma Caregivers
Apr. 12, 2024
May is Brain Tumor Awareness Month
Apr. 11, 2024
President’s Letter | April 2024
Apr. 11, 2024